Background: Gaucher’s disease (GD) is an autosomal recessive genetic disorder that results from pathogenic mutations of GBA gene encoding the enzyme glucocerebrosidase (acid β-glucosidase). Of the approximately 300 mutations associated with GD, 4 accounts for the majority of mutations seen in GD pat...

Full description

Bibliographic Details
Main Authors: Tahia H. Saleem, Mohammed H. Hassan, Ahmed El-Abd Ahmed, Ayat A. Sayed, Nahed A. Mohamed, Khalid I. Elsayh, Abdallah M.A.A. El-Ebidi, Norhan B.B. Mohammed
Format: Article
Language:English
Published: SpringerOpen 2017-07-01
Series:Egyptian Journal of Medical Human Genetics
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1110863016300696
_version_ 1811221587133726720
author Tahia H. Saleem
Mohammed H. Hassan
Ahmed El-Abd Ahmed
Ayat A. Sayed
Nahed A. Mohamed
Khalid I. Elsayh
Abdallah M.A.A. El-Ebidi
Norhan B.B. Mohammed
author_facet Tahia H. Saleem
Mohammed H. Hassan
Ahmed El-Abd Ahmed
Ayat A. Sayed
Nahed A. Mohamed
Khalid I. Elsayh
Abdallah M.A.A. El-Ebidi
Norhan B.B. Mohammed
author_sort Tahia H. Saleem
collection DOAJ
description Background: Gaucher’s disease (GD) is an autosomal recessive genetic disorder that results from pathogenic mutations of GBA gene encoding the enzyme glucocerebrosidase (acid β-glucosidase). Of the approximately 300 mutations associated with GD, 4 accounts for the majority of mutations seen in GD patients: N370S, L444P, 84 GG and IVS2+1. Aim: Establishing and providing, clinical and molecular backgrounds of pediatric patients with GD in Upper Egypt. Subjects and methods: The present study is a cross sectional study, carried out on 26 pediatric patients with GD. They were recruited from the pediatric outpatient clinics and inpatients Pediatric departments of Assiut and Qena University hospitals, Upper Egypt. Clinical evaluation and mutation analysis using commercially available strip assay kit after PCR amplification of the target gene were done for all included GD patients. Results: Consanguinity between patients’ parents was present in 73.1% of the included patients. 76.9% of included patients were of type 1 GD, while 23.1% were of type 3 GD and none of our patients was classified as type 2 GD. The main frequent clinical presentations of GD in this study were hepatosplenomegaly (88.5%); pallor (76.9%); abdominal distension (61.5%) and musculoskeletal involvement (37.1%). Neurological abnormalities of type 3 GD included in this study were squint, seizures and delayed mental development. Five different genotypes were detected, homozygous for the mutation L444P, homozygous for the mutation N370S, heterozygous for the mutations N370S and rec Ncil, heterozygous for IVS2 +1 and rec NciI, heterozygous for L444P and IVS2 +1. Conclusions: Non-neuropathic type 1 and type 3 GD were the only clinical types found in the present study. The most common mutant alleles found in this study were L444P and N370S.
first_indexed 2024-04-12T08:03:11Z
format Article
id doaj.art-3e66f328bc664d28b65423cc66806522
institution Directory Open Access Journal
issn 1110-8630
language English
last_indexed 2024-04-12T08:03:11Z
publishDate 2017-07-01
publisher SpringerOpen
record_format Article
series Egyptian Journal of Medical Human Genetics
spelling doaj.art-3e66f328bc664d28b65423cc668065222022-12-22T03:41:16ZengSpringerOpenEgyptian Journal of Medical Human Genetics1110-86302017-07-0118324925510.1016/j.ejmhg.2016.08.005Tahia H. Saleem0Mohammed H. Hassan1Ahmed El-Abd Ahmed2Ayat A. Sayed3Nahed A. Mohamed4Khalid I. Elsayh5Abdallah M.A.A. El-Ebidi6Norhan B.B. Mohammed7Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Assiut University, P.O. Box 71515, Assiut, EgyptDepartment of Medical Biochemistry and Molecular Biology, Qena Faculty of Medicine, South Valley University, P.O. Box No. 83523, Qena, EgyptDepartment of Pediatrics, Qena Faculty of Medicine, South Valley University, P.O. Box No. 83523, Qena, EgyptDepartment of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Assiut University, P.O. Box 71515, Assiut, EgyptDepartment of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Assiut University, P.O. Box 71515, Assiut, EgyptDepartment of Pediatrics, Faculty of Medicine, Assiut University, P.O. Box 71515, Assiut, EgyptDepartment of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Aswan University, P.O. Box No. 8152, Aswan, EgyptDepartment of Medical Biochemistry and Molecular Biology, Qena Faculty of Medicine, South Valley University, P.O. Box No. 83523, Qena, EgyptBackground: Gaucher’s disease (GD) is an autosomal recessive genetic disorder that results from pathogenic mutations of GBA gene encoding the enzyme glucocerebrosidase (acid β-glucosidase). Of the approximately 300 mutations associated with GD, 4 accounts for the majority of mutations seen in GD patients: N370S, L444P, 84 GG and IVS2+1. Aim: Establishing and providing, clinical and molecular backgrounds of pediatric patients with GD in Upper Egypt. Subjects and methods: The present study is a cross sectional study, carried out on 26 pediatric patients with GD. They were recruited from the pediatric outpatient clinics and inpatients Pediatric departments of Assiut and Qena University hospitals, Upper Egypt. Clinical evaluation and mutation analysis using commercially available strip assay kit after PCR amplification of the target gene were done for all included GD patients. Results: Consanguinity between patients’ parents was present in 73.1% of the included patients. 76.9% of included patients were of type 1 GD, while 23.1% were of type 3 GD and none of our patients was classified as type 2 GD. The main frequent clinical presentations of GD in this study were hepatosplenomegaly (88.5%); pallor (76.9%); abdominal distension (61.5%) and musculoskeletal involvement (37.1%). Neurological abnormalities of type 3 GD included in this study were squint, seizures and delayed mental development. Five different genotypes were detected, homozygous for the mutation L444P, homozygous for the mutation N370S, heterozygous for the mutations N370S and rec Ncil, heterozygous for IVS2 +1 and rec NciI, heterozygous for L444P and IVS2 +1. Conclusions: Non-neuropathic type 1 and type 3 GD were the only clinical types found in the present study. The most common mutant alleles found in this study were L444P and N370S.http://www.sciencedirect.com/science/article/pii/S1110863016300696Gaucher’s diseaseUpper EgyptClinical typesGenotypes
spellingShingle Tahia H. Saleem
Mohammed H. Hassan
Ahmed El-Abd Ahmed
Ayat A. Sayed
Nahed A. Mohamed
Khalid I. Elsayh
Abdallah M.A.A. El-Ebidi
Norhan B.B. Mohammed
Egyptian Journal of Medical Human Genetics
Gaucher’s disease
Upper Egypt
Clinical types
Genotypes
topic Gaucher’s disease
Upper Egypt
Clinical types
Genotypes
url http://www.sciencedirect.com/science/article/pii/S1110863016300696